Stem Cell/Cord Blood Banking Market Report 2026

Stem Cell/Cord Blood Banking Market Overview

• Stem Cell/Cord Blood Banking market size has reached to $13.33 billion in 2025 • Expected to grow to $24.47 billion in 2030 at a compound annual growth rate (CAGR) of 13% • Growth Driver: Growing Number Of Chronic Diseases To Drive Market Growth • Market Trend: Growing Adoption Of Peripheral Blood Stem Cell (PBSC) Services • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Stem Cell/Cord Blood Banking Market?

Stem cell or cord blood banking is the process of storing stem cells or blood from the umbilical cord. It is used to treat future injuries. By taking stem cells from the placenta and umbilical cord and preserving them for later use, cord blood banking can possibly save lives. The main cell types of stem cell/cord blood banking are adult stem cells, umbilical cord blood stem cells, and embryonic stem cells. Adult stem cells are a rare population of cells found in the body for the majority of postnatal life that give rise to a limited number of mature cell types that form the tissue in which they dwell. The different types of services include collection, processing, analysis, storage and involves various types of banks such as private banks, and public banks. The different applications include leukemia, anemia, thalassemia, autism, cerebral palsy, diabetes, and others.

What Is The Stem Cell/Cord Blood Banking Market Growth Forecast?

The stem cell/cord blood banking market size is expected to see rapid growth in the next few years. It will grow to $24.47 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to expanded therapeutic uses, affordability improvements, emerging market penetration, partnerships with hospitals, long-term storage demand. Major trends in the forecast period include private cord blood storage growth, hybrid public-private banking models, expanded stem cell applications, improved cryogenic storage, consumer awareness campaigns.

Global Stem Cell/Cord Blood Banking Market Segmentation

1) By Cell Type: Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells 2) By Service: Collection, Processing, Analysis, Storage 3) By Bank Type: Public, Private 4) By Application: Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications Subsegments: 1) By Adult Stem Cells: Hematopoietic Stem Cells (HSC), Mesenchymal Stem Cells (MSC), Neural Stem Cells (NSC), Induced Pluripotent Stem Cells (iPSCs) 2) By Umbilical Cord Blood Stem Cells: Hematopoietic Stem Cells (HSC) From Cord Blood, Mesenchymal Stem Cells (MSC) From Cord Blood 3) By Embryonic Stem Cells: Embryonic Stem Cells (ESCs) From Human Embryos, Stem Cells Derived From Human Embryonic Germ Cells

What Is The Driver Of The Stem Cell/Cord Blood Banking Market?

The rising prevalence of chronic diseases is expected to propel the growth of stem cell/cord blood banking market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. As chronic diseases often lack effective treatments, the regenerative potential of stem cells and cord blood is increasingly explored for therapeutic purposes. Stem cell transplants, personalized medicine, and clinical research into novel therapies for chronic conditions are all expanding, creating a higher demand for banking services. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising prevalence of chronic diseases is driving the growth of the stem cell or cord blood banking market.

Key Players In The Global Stem Cell/Cord Blood Banking Market

Major companies operating in the stem cell/cord blood banking market are Cryo-Cell International Inc, Esperite NV, Americord Registry LLC, China Cord Blood Corporation, Cordlife Group Ltd, CordVida, Cryo Stemcell, ReeLabs Pvt Ltd, Smart Cells International Ltd, Stemade Biotech Pvt Ltd, ViaCord Inc, LifeCell International, Cryoviva Biotech Pvt Ltd, Cord Blood America Inc, StemCyte Inc, Cord Blood Registry Systems Inc, Healthbanks Biotech Usa Inc, Cryo-save Private Ltd, New York Cord Blood Center, CryoHoldco, Vita 34 International AG, Reliance Life Sciences Pvt Ltd, Maze Cord Blood Laboratories, Cells4Life Group LLP

Global Stem Cell/Cord Blood Banking Market Trends and Insights

Major companies operating in the stemcell/cord blood banking market are developing peripheral blood stem cell processing and storage service to gain a competitive edge in the market. Peripheral blood stem cell processing and storage refer to the collection, processing, testing, and cryopreservation of haematopoietic stem cells (HSCs) obtained from a patient's peripheral blood. For instance, in February 2023, Cordlife Group Limited, a Singapore-based healthcare company launched new peripheral blood stem cell (PBSC) processing and storage service in Singapore. This service is designed to support patients requiring haematopoietic stem cell transplantation as part of their treatment for various blood-related diseases, including leukemia, myeloma, and lymphoma. Cordlife’s collaboration with the Centre for Clinical Haematology (CFCH) allows eligible patients to undergo stem cell mobilization and harvesting, with Cordlife handling the subsequent processing, testing, and cryopreservation of PBSCs. This new service aims to improve treatment outcomes for individuals requiring haematopoietic stem cell transplants and expand Cordlife’s range of banking services in Singapore.

What Are Latest Mergers And Acquisitions In The Stem Cell/Cord Blood Banking Market?

In July 2024, Cytomed Therapeutics, a Singapore based biopharmaceutical company, acquired Cellsafe International Sdn Bhd for US $490000. The acquisition is intended to strengthen its strategy in developing allogeneic, off-the-shelf donor-derived gamma delta (γδ) T cell therapies for treating solid and liquid cancers. Cellsafe International Sdn Bhd is a Malaysia-basedcord blood bank company.

Regional Outlook

North America was the largest region in the stem cell/cord blood banking market in 2025. Western Europe was the second largest region in the stem cell/cord blood banking market analysis. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Stem Cell/Cord Blood Banking Market?

The stem cell/cord blood banking global market includes revenues earned by entities by providing services such as cryopreservation and collection services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Stem Cell/Cord Blood Banking Market Report 2026?

The stem cell/cord blood banking market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell/cord blood banking industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.